{"title":"头颈部鳞状细胞癌同步放化疗患者急性放射性皮炎(RD)程度与皮肤剂量分布的相关性","authors":"Sattwik Basu, Subrata Chatterjee, Kaustav Chatterjee, Sattama Samanta, Solanki Saha, Sk Toslim Hossain, Pritha Mondal, Shyamal Biswas","doi":"10.5603/rpor.102824","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Radiation dermatitis (RD) or skin toxicity is one of the most common acute side effects of radiation in head and neck cancer patients. This study aims to correlate the pattern of volumetric-modulated arc therapy (VMAT) dose distribution to the skin with the grades of RD.</p><p><strong>Materials and methods: </strong>80 plans of histopathologically proven squamous cell carcinoma head and neck patients already treated with definitive concurrent chemoradiation [66-70 Gy in 33-35# or 66 Gy in 30# in simultaneous integrated boost (SIB), with concurrent Cisplatin 100 mg/m<sup>2</sup> 3 weekly] at our institution between November 2022 and November 2023 were retrieved from our digital archives. For each plan, 1 ring structure was created 3mm below the external skin surface, and the parameters V<sub>40</sub>, V<sub>50</sub>, V<sub>60</sub> and D<sub>max</sub> were collected from the same. These parameters were correlated with grades of RD as per Common Terminology Criteria for Adverse Events (CTCAE) v5.0. The statistical analysis was done using MedCalc software version 22.021.</p><p><strong>Results: </strong>The incidence of G2/G3 RD was 52.5%, and its incidence was significantly correlated with all of the four parameters. Statistically significant (p < 0.001) dosimetric predictive accuracy was provided by 71.66 cc, 29.98 cc and 7.624 cc of the 3mm skin ring V<sub>40,</sub> V<sub>50</sub> and V<sub>60</sub>, respectively.</p><p><strong>Conclusion: </strong>The dose distribution pattern to a skin layer stationed 3mm below the surface may help predict the development of severe RD in head and neck cancer patients receiving concurrent chemoradiation.</p>","PeriodicalId":47283,"journal":{"name":"Reports of Practical Oncology and Radiotherapy","volume":"29 5","pages":"579-587"},"PeriodicalIF":1.2000,"publicationDate":"2024-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11698550/pdf/","citationCount":"0","resultStr":"{\"title\":\"Correlation of degree of acute radiation dermatitis (RD) with skin dose distribution in head and neck squamous cell carcinoma patients treated with definitive concurrent chemoradiation.\",\"authors\":\"Sattwik Basu, Subrata Chatterjee, Kaustav Chatterjee, Sattama Samanta, Solanki Saha, Sk Toslim Hossain, Pritha Mondal, Shyamal Biswas\",\"doi\":\"10.5603/rpor.102824\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Radiation dermatitis (RD) or skin toxicity is one of the most common acute side effects of radiation in head and neck cancer patients. This study aims to correlate the pattern of volumetric-modulated arc therapy (VMAT) dose distribution to the skin with the grades of RD.</p><p><strong>Materials and methods: </strong>80 plans of histopathologically proven squamous cell carcinoma head and neck patients already treated with definitive concurrent chemoradiation [66-70 Gy in 33-35# or 66 Gy in 30# in simultaneous integrated boost (SIB), with concurrent Cisplatin 100 mg/m<sup>2</sup> 3 weekly] at our institution between November 2022 and November 2023 were retrieved from our digital archives. For each plan, 1 ring structure was created 3mm below the external skin surface, and the parameters V<sub>40</sub>, V<sub>50</sub>, V<sub>60</sub> and D<sub>max</sub> were collected from the same. These parameters were correlated with grades of RD as per Common Terminology Criteria for Adverse Events (CTCAE) v5.0. The statistical analysis was done using MedCalc software version 22.021.</p><p><strong>Results: </strong>The incidence of G2/G3 RD was 52.5%, and its incidence was significantly correlated with all of the four parameters. Statistically significant (p < 0.001) dosimetric predictive accuracy was provided by 71.66 cc, 29.98 cc and 7.624 cc of the 3mm skin ring V<sub>40,</sub> V<sub>50</sub> and V<sub>60</sub>, respectively.</p><p><strong>Conclusion: </strong>The dose distribution pattern to a skin layer stationed 3mm below the surface may help predict the development of severe RD in head and neck cancer patients receiving concurrent chemoradiation.</p>\",\"PeriodicalId\":47283,\"journal\":{\"name\":\"Reports of Practical Oncology and Radiotherapy\",\"volume\":\"29 5\",\"pages\":\"579-587\"},\"PeriodicalIF\":1.2000,\"publicationDate\":\"2024-12-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11698550/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Reports of Practical Oncology and Radiotherapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5603/rpor.102824\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q4\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Reports of Practical Oncology and Radiotherapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5603/rpor.102824","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
Correlation of degree of acute radiation dermatitis (RD) with skin dose distribution in head and neck squamous cell carcinoma patients treated with definitive concurrent chemoradiation.
Background: Radiation dermatitis (RD) or skin toxicity is one of the most common acute side effects of radiation in head and neck cancer patients. This study aims to correlate the pattern of volumetric-modulated arc therapy (VMAT) dose distribution to the skin with the grades of RD.
Materials and methods: 80 plans of histopathologically proven squamous cell carcinoma head and neck patients already treated with definitive concurrent chemoradiation [66-70 Gy in 33-35# or 66 Gy in 30# in simultaneous integrated boost (SIB), with concurrent Cisplatin 100 mg/m2 3 weekly] at our institution between November 2022 and November 2023 were retrieved from our digital archives. For each plan, 1 ring structure was created 3mm below the external skin surface, and the parameters V40, V50, V60 and Dmax were collected from the same. These parameters were correlated with grades of RD as per Common Terminology Criteria for Adverse Events (CTCAE) v5.0. The statistical analysis was done using MedCalc software version 22.021.
Results: The incidence of G2/G3 RD was 52.5%, and its incidence was significantly correlated with all of the four parameters. Statistically significant (p < 0.001) dosimetric predictive accuracy was provided by 71.66 cc, 29.98 cc and 7.624 cc of the 3mm skin ring V40, V50 and V60, respectively.
Conclusion: The dose distribution pattern to a skin layer stationed 3mm below the surface may help predict the development of severe RD in head and neck cancer patients receiving concurrent chemoradiation.
期刊介绍:
Reports of Practical Oncology and Radiotherapy is an interdisciplinary bimonthly journal, publishing original contributions in clinical oncology and radiotherapy, as well as in radiotherapy physics, techniques and radiotherapy equipment. Reports of Practical Oncology and Radiotherapy is a journal of the Polish Society of Radiation Oncology, the Czech Society of Radiation Oncology, the Hungarian Society for Radiation Oncology, the Slovenian Society for Radiotherapy and Oncology, the Polish Study Group of Head and Neck Cancer, the Guild of Bulgarian Radiotherapists and the Greater Poland Cancer Centre, affiliated with the Spanish Society of Radiotherapy and Oncology, the Italian Association of Radiotherapy and the Portuguese Society of Radiotherapy - Oncology.